Clinical Trials Browser

Esophageal Neoplasms

Carcinoma, Neuroendocrine

Hematologic Neoplasms

Brain Neoplasms

Glioma, Parkinson Disease, Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms, Sarcoma, Osteosarcoma

Breast Neoplasms

Lung Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Hepatic Malignancies

Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

Breast Cancer Metastases

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Breast Neoplasms

Histologically-confirmed Malignancies

Lymphoma, Non-Hodgkin

Glioblastoma

Carcinoma, Hepatocellular, Liver Neoplasms

Disease, Prostatic Neoplasms

Prostatic Neoplasms, Recurrence

Rectal Neoplasms

Breast Neoplasms

Uterine Cervical Neoplasms

Clinical Trials

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

CXCR4-targeted PET/CT Imaging in Hematological Malignancies

68Ga-FAPI PET/CT in Malignant Tumors

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

qMAP

Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.

Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

PET/MR Imaging in Lung Cancer

BCMetPats

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

PIPPIN

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

REPEAT

WHENII

PET CT Re-Planning NSCLC (4DCT-PET)

PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

TEP-LYMPHOME

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

IMMETAOS

PROST-I

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

PRENT-LARC

Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study

New Indications for Ultrasound in the Staging of Cervical Cancer